BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,122,573 | -86.5% | 56,242 | -83.7% | 0.00% | -80.0% |
| Q2 2023 | $15,681,798 | -27.8% | 344,201 | -35.7% | 0.01% | -44.4% |
| Q1 2023 | $21,710,024 | +64.9% | 535,257 | +107.2% | 0.01% | +50.0% |
| Q4 2022 | $13,164,429 | +52.8% | 258,278 | +61.5% | 0.01% | +50.0% |
| Q3 2022 | $8,615,000 | -48.9% | 159,947 | -39.1% | 0.00% | -42.9% |
| Q2 2022 | $16,864,000 | -90.4% | 262,560 | -88.4% | 0.01% | -87.7% |
| Q1 2022 | $175,118,000 | +484.8% | 2,258,434 | +547.4% | 0.06% | +470.0% |
| Q4 2021 | $29,944,000 | -28.0% | 348,832 | -32.5% | 0.01% | -33.3% |
| Q3 2021 | $41,586,000 | +56.0% | 517,044 | +56.1% | 0.02% | +50.0% |
| Q2 2021 | $26,656,000 | +51.3% | 331,122 | +58.5% | 0.01% | +25.0% |
| Q1 2021 | $17,614,000 | +147.2% | 208,846 | +135.2% | 0.01% | +166.7% |
| Q4 2020 | $7,125,000 | -77.4% | 88,805 | -77.3% | 0.00% | -84.2% |
| Q3 2020 | $31,509,000 | +117.0% | 391,800 | +132.4% | 0.02% | +72.7% |
| Q2 2020 | $14,518,000 | +325.2% | 168,615 | +301.0% | 0.01% | +266.7% |
| Q1 2020 | $3,414,000 | -53.3% | 42,053 | -51.9% | 0.00% | -70.0% |
| Q4 2019 | $7,305,000 | +492.0% | 87,347 | +519.1% | 0.01% | +400.0% |
| Q3 2019 | $1,234,000 | -87.9% | 14,109 | -88.7% | 0.00% | -88.9% |
| Q2 2019 | $10,206,000 | +11.1% | 124,611 | +10.3% | 0.02% | +20.0% |
| Q1 2019 | $9,183,000 | +253.6% | 112,935 | +186.2% | 0.02% | +150.0% |
| Q4 2018 | $2,597,000 | -35.1% | 39,454 | -23.9% | 0.01% | -25.0% |
| Q3 2018 | $4,000,000 | -86.8% | 51,878 | -87.3% | 0.01% | -88.6% |
| Q2 2018 | $30,242,000 | +589.5% | 409,559 | +507.4% | 0.07% | +536.4% |
| Q1 2018 | $4,386,000 | -37.7% | 67,433 | -38.0% | 0.01% | -45.0% |
| Q4 2017 | $7,036,000 | +776.2% | 108,847 | +750.2% | 0.02% | +566.7% |
| Q3 2017 | $803,000 | +223.8% | 12,802 | +212.2% | 0.00% | +200.0% |
| Q2 2017 | $248,000 | -56.1% | 4,100 | -62.4% | 0.00% | -66.7% |
| Q1 2017 | $565,000 | -14.5% | 10,900 | -26.9% | 0.00% | 0.0% |
| Q4 2016 | $661,000 | -62.3% | 14,902 | -59.6% | 0.00% | -62.5% |
| Q3 2016 | $1,754,000 | -31.6% | 36,865 | -35.0% | 0.01% | -38.5% |
| Q2 2016 | $2,564,000 | +44.8% | 56,687 | +31.4% | 0.01% | +30.0% |
| Q1 2016 | $1,771,000 | +100.3% | 43,132 | +86.1% | 0.01% | +100.0% |
| Q4 2015 | $884,000 | -74.2% | 23,179 | -77.8% | 0.01% | -76.2% |
| Q3 2015 | $3,429,000 | -59.8% | 104,401 | -14.3% | 0.02% | -61.8% |
| Q2 2015 | $8,522,000 | +2666.9% | 121,859 | +2608.0% | 0.06% | +2650.0% |
| Q1 2015 | $308,000 | -31.1% | 4,500 | -26.3% | 0.00% | -33.3% |
| Q4 2014 | $447,000 | -93.6% | 6,102 | -93.6% | 0.00% | -96.1% |
| Q1 2014 | $6,973,000 | – | 94,768 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |